 To demonstrate superiority of QVA149 11050 μg once daily compared to tiotropium 18 μg once daily in terms of trough forced expiratory volume in 1 second FEV1 mean of 45 min and 15 min pre-dose following 12 weeks of treatment in mild to moderate symptomatic COPD patients 